Stay updated on CSJ117 Efficacy in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the CSJ117 Efficacy in Severe Asthma Clinical Trial page.

Latest updates to the CSJ117 Efficacy in Severe Asthma Clinical Trial page
- Check5 days agoChange DetectedThe site footer revision identifier changed from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check12 days agoChange DetectedThe clinical trial page now displays the study record for CSJ117 in adults with severe uncontrolled asthma, including its terminated status, study design, eligibility criteria, locations, and outcome measures, rather than a forbidden-access error.SummaryDifference100%

- Check19 days agoChange DetectedThe site footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check33 days agoChange DetectedAn NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence,” and the site revision number changes from v3.7.1 to v3.7.2. The study page itself continues to show a 403 error.SummaryDifference1%

- Check47 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.1 instead of v3.7.0. The study page continues to display a 403 error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error page, indicating restricted access to the study content, with the 403 message and site footer visible.SummaryDifference0.5%

Stay in the know with updates to CSJ117 Efficacy in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CSJ117 Efficacy in Severe Asthma Clinical Trial page.